Yahoo
NasdaqCM - Delayed Quote USD

Cellyan Biotechnology Co., Ltd (HKPD)

1.9800 -0.2100 (-9.59%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
13,433.5070
13,433.5070
20,313.8180
16,688.3640
12,555.9910
Cost of Revenue
12,047.1980
12,047.1980
17,898.6590
13,129.6990
9,817.0660
Gross Profit
1,386.3090
1,386.3090
2,415.1590
3,558.6650
2,738.9250
Operating Expense
2,389.7480
2,389.7480
2,214.3930
1,885.4170
1,661.8510
Operating Income
-1,003.4390
-1,003.4390
200.7660
1,673.2480
1,077.0740
Net Non Operating Interest Income Expense
-133.3950
-133.3950
-95.9260
-82.2920
-23.0230
Other Income Expense
8.5370
8.5370
-68.7280
-64.9870
-33.2810
Pretax Income
-1,128.2970
-1,128.2970
36.1120
1,525.9690
1,020.7700
Tax Provision
7.6660
7.6660
63.1680
196.2520
22.5740
Net Income Common Stockholders
-1,135.9630
-1,135.9630
-27.0560
1,329.7170
998.1960
Diluted NI Available to Com Stockholders
-1,135.9630
-1,135.9630
-27.0560
1,329.7170
998.1960
Basic EPS
-0.07
-1.38
-0.06
2.42
1.81
Diluted EPS
-0.07
-1.38
-0.06
2.42
1.81
Basic Average Shares
16,349.9860
817.4990
510.2730
550
550
Diluted Average Shares
16,349.9860
817.4990
510.2730
550
550
Total Operating Income as Reported
-994.9020
-994.9020
132.0380
1,608.2610
1,043.7930
Total Expenses
14,436.9460
14,436.9460
20,113.0520
15,015.1160
11,478.9170
Net Income from Continuing & Discontinued Operation
-1,135.9630
-1,135.9630
-27.0560
1,329.7170
998.1960
Normalized Income
-1,143.0914
-1,143.0914
21.5510
1,384.1938
1,028.7487
Interest Income
0.4540
0.4540
1.7410
0.4740
0.2190
Interest Expense
133.8490
133.8490
97.6670
82.7660
23.2420
Net Interest Income
-133.3950
-133.3950
-95.9260
-82.2920
-23.0230
EBIT
-994.4480
-994.4480
133.7790
1,608.7350
1,044.0120
EBITDA
-307.3310
-307.3310
1,207.1500
2,534.3110
1,758.5980
Reconciled Cost of Revenue
12,047.1980
12,047.1980
17,898.6590
13,129.6990
9,817.0660
Reconciled Depreciation
687.1170
687.1170
1,073.3710
925.5760
714.5860
Net Income from Continuing Operation Net Minority Interest
-1,135.9630
-1,135.9630
-27.0560
1,329.7170
998.1960
Total Unusual Items Excluding Goodwill
8.5370
8.5370
-58.2120
-62.5170
-31.2400
Total Unusual Items
8.5370
8.5370
-58.2120
-62.5170
-31.2400
Normalized EBITDA
-315.8680
-315.8680
1,265.3620
2,596.8280
1,789.8380
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0001
0
Tax Effect of Unusual Items
1.4086
1.4086
-9.6050
-8.0402
-0.6873
3/31/2023 - 1/15/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: